Antipsychotic (AP) use may lead to numerous side effects which may affect rehabilitation outcomes. A retrospective cohort study was carried out on 448 hip fractured patients admitted to a post-acute geriatric rehabilitation center. Functional improvement was measured by the Functional Independence Measure (FIM), motor FIM (mFIM), and mFIM effectiveness. A multiple linear regression model and regression analysis was used to evaluate the level of association between AP use and achievement of favorable functional gain. AP users exhibited lower functional ability on admission and at discharge, achieved a significantly lower functional gain and required longer rehabilitation time compared with nonusers. AP use by post-acute hip fractured patients negatively affects their chances of achieving favorable rehabilitation outcome after adjustment for confounders.
ArnoldI.StraubeK.HimmelW.HeinemannS.WeissV.HeydenL.. . . NaurR. (2017). High prevalence of prescription of psychotropic drugs for older patients in a general hospital. BMC Pharmacology and Toxicology, 18, Article 76.
2.
DrubachD. A.KellyM. P.TaraganoF. E. (1994). The Montebello Rehabilitation Factor Score. Journal of Neurologic Rehabilitation, 8, 92–96.
3.
FengZ.HirdesJ. P.SmithT. F.Finne-SoveriH.ChiI.Du PasquierJ. N.MorV. (2009). Use of physical restraints and antipsychotic medications in nursing homes: A cross-national study. International Journal of Geriatric Psychiatry, 24, 1110–1118.
4.
FickD. M.SemlaT. P.SteinmanM.BeizerJ.BrandtN.DombrowskiR.SanduS. (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67, 674–679.
5.
FlurieR. W.GonzalesJ. P.TataA. L.MillsteinL. S.GulatiM. (2015). Hospital delirium treatment: Continuation of antipsychotic therapy from the intensive care unit to discharge. American Journal of Health System Pharmacy, 72, S133–S139.
6.
FolsteinM. F.FolsteinS. E.McHugeP. R. (1975). “Mini-Mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
7.
GaudreauJ. D.GagnonP. (2005). Psychotogenic drugs and delirium pathogenesis: The central role of the thalamus. Medical Hypotheses, 64, 471–475.
8.
GellerA. I.NopkhunW.Dows-MartinezM. N.StrasserD. C. (2012). Polypharmacy and the role of physical medicine and rehabilitation. PM&R, 4, 198–219.
9.
GreenblattH. K.GreenblattD. J. (2016). Use of antipsychotics for the treatment of behavioral symptoms of Dementia. The Journal of Clinical Pharmacology, 56, 1048–1057.
10.
GuidetB.ValletH.BoddaertJ.de LangeD. W.MorandiA.LeblancG.FlaattenH. (2018). Caring for the critically ill patients over 80: A narrative review. Annals of Intensive Care, 8, Article 114.
11.
HamiltonB. B.GrangerC. V.SherwinF. S.ZieleznyM.TashmanJ. S. (1987). A uniform national data system for medical rehabilitation. In FuhrerM. J. (Ed.), Rehabilitation outcomes: Analysis and measurement (pp. 137–147). Paul H. Brooks.
12.
HershkovitzA.AngelC.BrillS.NissanR. (2018). The association between anticholinergic drug use and rehabilitation outcome in post-acute hip fractured patients: A retrospective cohort study. Drugs and Aging, 35, 333–341.
13.
HershkovitzA.KalandariovZ.HermushV.WeissR.BrillS. (2007). Factors affecting short-term rehabilitation outcomes of disabled elderly patients with proximal hip fracture. Archives of Physical Medicine and Rehabilitation, 88, 916–921.
14.
HerutiR. J.LuskyA.BarellV.OhryA.AdunskyA. (1999). Cognitive status at admission: Does it affect the rehabilitation outcome of elderly patients with hip fracture?Archives of Physical Medicine and Rehabilitation, 80, 432–436.
15.
JalbertJ. J.EatonC. B.MillerS. C.LapaneK. L. (2010). Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. Journal of the American Medical Directors Association, 11, 120–127.
16.
JungH. Y.MeucciM.UnruhM. A.MorV.DosaD. (2013). Antipsychotic use in nursing home residents admitted with hip fracture. Journal of the American Geriatrics Society, 61, 101–106.
17.
KernsJ. W.WinterJ. D.WinterK. M.KernsC. C.EtzR. S. (2018). Caregiver perspectives about using antipsychotics and other medications for symptoms of dementia. The Gerontologist, 58, e35–e45.
18.
KohmG. C.ChenC. H.PetrellaR.AmardeepT. (2013). Rehabilitation impact indices and their independent predictors: A systematic review. BMJ Open, 3, Article e003483.
19.
KoponenM.TaipaleH.LavikainenP.TanskanenA.TihoneneJ.TolppanenA. M.. . . HartikainenS. (2017). Antipsychotic use and the risk of hip fracture among community-dwelling persons with Alzheimer’s disease. Journal of Clinical Psychiatry, 78, e257–e263.
20.
Lapeyre-MestreM. (2016). A review of adverse outcomes associated with psychoactive drug use in nursing home residents with dementia. Drugs and Aging, 33, 865–888.
21.
LiperotiR.PedoneC.CorsonelloA. (2008). Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD). Current Neuropharmacology, 6, 117–124.
22.
MaglioneM.MaherA. R.HuJ.WangZ.ShanmanR.ShekelleP. G.PerryT. (2011). Off-label use of atypical antipsychotics: An update (Report No: 11-EHC087-EF). Agency for Healthcare Research and Quality.
23.
MarcantonioE. R.FlackerJ. M.WrightR. J.ResnickN. M. (2001). Reducing delirium after hip fracture: A randomized trial. Journal of the American Geriatrics Society, 49, 516–522.
24.
MehtaS.ChenH.JohnsonM. L.AparasuR. R. (2010). Risk of falls and fractures in older adults using antipsychotic agents: A propensity-matched retrospective cohort study. Drugs & Aging, 27, 815–829.
25.
MonetteJ.MonetteM.SourialN.VandalA. C.WolfsonC.ChampouxN.. . . SavoieM. L. (2013). Effect of an interdisciplinary educational program on antipsychotic prescribing among residents with dementia in two long-term care centers. Journal of Applied Gerontology, 32, 833–854.
26.
MorrisonR. S.ChassinM. R.SiuA. L. (1998). The medical consultant’s role in caring for patients with hip fracture. Annals of Internal Medicine, 128, 1010–1020.
27.
NakamichiM.WakabayashiH.NishiokaS.MomosakiR. (2019). Influence of antipsychotics on functional prognosis after geriatric hip fracture. The Journal of Nutrition, Health and Aging, 23, 381–385.
28.
OderdaL. H.YoungJ. R.AscheC. V.PepperG. A. (2012). Psychotropic-related hip fractures: Meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs. Annals of Pharmacotherapy, 46, 917–928.
29.
OhE. S.FongT. G.HshiehT. T.InouyeS. K. (2017). Delirium in older persons: Advances in diagnosis and treatment. The Journal of the American Medical Association, 318, 1161–1174.
30.
PanulaJ.PihlajamäkiH.MattilaV. M.JaatinenP.VahlbergT.AarnioP.KivelaS. (2011). Mortality and cause of death in hip fracture patients aged 65 or older: A population-based study. BMC Musculoskeletal Disorders, 12, Article 105.
31.
PrattN.RougheadE. E.SalterA.RyanP. (2012). Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: A systematic review. BMC Medical of Research Methodology, 12, Article 72.
32.
RollandY.PillardF.Lauwers-CancesV.BusquereF.VellasB.LafontC. (2004). Rehabilitation outcome of elderly patients with hip fracture and cognitive impairment. Disability and Rehabilitation, 26, 425–431.
33.
Shiri-SharvitO.AradM.MizrahiE. H.FleissigY.AdunskyA. (2005). The association between psychotropic medication use and functional outcome of elderly hip-fracture patients undergoing rehabilitation. Archives of Physical Medicine and Rehabilitation, 86, 1389–1393.
34.
SteinbergM.LyketsosC. G. (2012). Atypical antipsychotic use in patients with dementia: Managing safety concerns. American Journal of Psychiatry, 169, 900–906.
35.
TomichekJ. E.StollingsJ. L.PandharipandeP. P.ChandrasekharR.ElyW. E.GirardT. D. (2016). Antipsychotic prescribing patterns during and after critical illness: A prospective cohort study. Critical Care, 20, Article 378.
36.
Uriz-OtanoF.Uriz-OtanoJ. I.MalafarinaV. (2015). Factors associated with short-term functional recovery in elderly people with a hip fracture. Influence of cognitive impairment. Journal of the American Medical Directors Association, 16, 215–220.
37.
VeroneseN.MaggiS. (2018). Epidemiology and social costs of hip fracture. Injury, 49, 1458–1460.
38.
WarnockC. A.FergusonI. D.LamJ. (2014). Psychotropic drug prescribing survey in a Canadian rehabilitation and complex care facility. The Consultant Pharmacist, 29, 387–399.
